Prof Lily Zhou

Dr. Lily Zhou is currently the Chief of the Hematology Department at Sino United Health in Shanghai China.

Dr. Zhou earned her M.D & Ph.D. in Hematology from the Naval Medical University and postdoctoral scholarship in University of California, San Francisco (UCSF).

As a Chief Physician, she has been working in the area of myeloma and lymphoma since 2004, with more than 20 years of extensive clinical experience especially for novel treatment strategies, such as immune-therapy, targeted therapy, CART cell therapy, etc.

Dr. Zhou is a committee member of Shanghai Hematology Association, Hematology Translational Medicine Committee of Shanghai Pharmaceutical Industry Association, Hematological Disease Rehabilitation Committee of China, American Society of Clinical Oncology ( ASCO ), and Experimental Hematology and Transplantation Immunology Group of Hematology in China.

Dr. Zhou has led multiple academic projects including the funding from the Myeloma Translational Medicine of UCSF, the National Science Foundation of China, the Shanghai Pujiang Talent Project, Myeloma Special Funding of Chinese Medical Association.